Lymphoma Stocks List

Recent Signals

Date Stock Signal Type
2020-01-17 AFMD NR7 Range Contraction
2020-01-17 AFMD Crossed Above 200 DMA Bullish
2020-01-17 AFMD Pocket Pivot Bullish Swing Setup
2020-01-17 AFMD Stochastic Reached Overbought Strength
2020-01-17 BPTH Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-01-17 BPTH MACD Bullish Signal Line Cross Bullish
2020-01-17 CALA Pocket Pivot Bullish Swing Setup
2020-01-17 CALA New 52 Week Closing High Bullish
2020-01-17 CALA New 52 Week High Strength
2020-01-17 CGIX NR7 Range Contraction
2020-01-17 CGIX Narrow Range Bar Range Contraction
2020-01-17 CGIX Spinning Top Other
2020-01-17 CGIX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-01-17 CNST New Uptrend Bullish
2020-01-17 CNST Crossed Above 50 DMA Bullish
2020-01-17 CNST 180 Bullish Setup Bullish Swing Setup
2020-01-17 EGRX Bollinger Band Squeeze Range Contraction
2020-01-17 EGRX Fell Below 20 DMA Bearish
2020-01-17 FTSV New 52 Week High Strength
2020-01-17 FTSV Pocket Pivot Bullish Swing Setup
2020-01-17 FTSV Expansion Breakout Bullish Swing Setup
2020-01-17 FTSV New 52 Week Closing High Bullish
2020-01-17 FTSV Wide Range Bar Range Expansion
2020-01-17 GMAB 50 DMA Support Bullish
2020-01-17 GMAB NR7 Range Contraction
2020-01-17 GMAB Narrow Range Bar Range Contraction
2020-01-17 MTEM Fell Below 20 DMA Bearish
2020-01-17 MTEM Bollinger Band Squeeze Range Contraction
2020-01-17 MTEM Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-01-17 NEO Upper Bollinger Band Walk Strength
2020-01-17 SGEN Lower Bollinger Band Walk Weakness
2020-01-17 TEVA Slingshot Bullish Bullish Swing Setup
2020-01-17 TGTX New 52 Week High Strength
2020-01-17 TGTX Upper Bollinger Band Walk Strength

Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The name often refers to just the cancerous versions rather than all such tumors. Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The enlarged lymph nodes are usually painless. The sweats are most common at night.There are dozens of subtypes of lymphomas. The two main categories of lymphomas are Hodgkin's lymphomas (HL) and the non-Hodgkin lymphomas (NHL). The World Health Organization (WHO) includes two other categories as types of lymphoma: multiple myeloma and immunoproliferative diseases. About 90% of lymphomas are non-Hodgkin lymphomas. Lymphomas and leukemias are a part of the broader group of tumors of the hematopoietic and lymphoid tissues.Risk factors for Hodgkin lymphoma include infection with Epstein–Barr virus and a history of the disease in the family. Risk factors for common types of non-Hodgkin lymphomas include autoimmune diseases, HIV/AIDS, infection with human T-lymphotropic virus, immunosuppressant medications, and some pesticides. Eating large amounts of red meat and tobacco smoking may also increase the risk. Diagnosis, if enlarged lymph nodes are present, is usually by lymph node biopsy. Blood, urine, and bone marrow testing may also be useful in the diagnosis. Medical imaging may then be done to determine if and where the cancer has spread. Lymphoma most often spreads to the lungs, liver, and brain.
Treatment may involve one or more of the following: chemotherapy, radiation therapy, targeted therapy, and surgery. In some non-Hodgkin lymphomas, an increased amount of protein produced by the lymphoma cells causes the blood to become so thick that plasmapheresis is performed to remove the protein. Watchful waiting may be appropriate for certain types. The outcome depends on the subtype with some being curable and treatment prolonging survival in most. The five-year survival rate in the United States for all Hodgkin lymphoma subtypes is 85%, while that for non-Hodgkin lymphomas is 69%. Worldwide, lymphomas developed in 566,000 people in 2012 and caused 305,000 deaths. They make up 3–4% of all cancers, making them as a group the seventh-most common form. In children, they are the third-most common cancer. They occur more often in the developed world than the developing world.

More about Lymphoma